RhumbLine Advisers’s Healthcare Realty HR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.2M Sell
893,433
-8,408
-0.9% -$147K 0.01% 856
2025
Q4
$15.3M Sell
901,841
-31,398
-3% -$559K 0.01% 861
2025
Q3
$16.8M Sell
933,239
-46,023
-5% -$778K 0.01% 826
2025
Q2
$15.5M Sell
979,262
-56,287
-5% -$856K 0.01% 843
2025
Q1
$17.5M Sell
1,035,549
-18,505
-2% -$307K 0.02% 754
2024
Q4
$17.9M Sell
1,054,054
-20,946
-2% -$368K 0.02% 760
2024
Q3
$19.5M Sell
1,075,000
-40,518
-4% -$718K 0.02% 730
2024
Q2
$18.4M Sell
1,115,518
-14,263
-1% -$218K 0.02% 717
2024
Q1
$16M Sell
1,129,781
-40,037
-3% -$604K 0.02% 812
2023
Q4
$20.2M Sell
1,169,818
-22,931
-2% -$350K 0.02% 679
2023
Q3
$18.2M Sell
1,192,749
-19,929
-2% -$354K 0.02% 677
2023
Q2
$22.9M Buy
1,212,678
+32,016
+3% +$618K 0.03% 585
2023
Q1
$22.8M Sell
1,180,662
-13,683
-1% -$276K 0.03% 544
2022
Q4
$23M Buy
1,194,345
+55,495
+5% +$1.09M 0.03% 522
2022
Q3
$23.7M Buy
1,138,850
+880,786
+341% +$22.4M 0.04% 463
2022
Q2
$7.2M Buy
258,064
+41,658
+19% +$1.24M 0.01% 1068
2022
Q1
$6.78M Sell
216,406
-23,874
-10% -$752K 0.01% 1145
2021
Q4
$8.02M Buy
240,280
+998
+0.4% +$33.3K 0.01% 1106
2021
Q3
$7.1M Sell
239,282
-18,963
-7% -$553K 0.01% 1143
2021
Q2
$6.89M Sell
258,245
-11,558
-4% -$327K 0.01% 1240
2021
Q1
$7.44M Sell
269,803
-9,000
-3% -$252K 0.01% 1177
2020
Q4
$7.68M Buy
278,803
+8,049
+3% +$212K 0.01% 1096
2020
Q3
$7.04M Sell
270,754
-9,787
-3% -$257K 0.01% 954
2020
Q2
$7.44M Buy
280,541
+9,313
+3% +$239K 0.01% 938
2020
Q1
$6.58M Buy
271,228
+60,167
+29% +$1.82M 0.01% 870
2019
Q4
$6.39M Buy
211,061
+16,272
+8% +$486K 0.01% 1112
2019
Q3
$5.72M Buy
194,789
+8,253
+4% +$231K 0.01% 1113
2019
Q2
$5.12M Sell
186,536
-2,616
-1% -$73.7K 0.01% 1186
2019
Q1
$5.41M Sell
189,152
-27,023
-13% -$752K 0.01% 1132
2018
Q4
$5.47M Buy
216,175
+6,032
+3% +$160K 0.01% 1049
2018
Q3
$5.61M Sell
210,143
-10,681
-5% -$294K 0.01% 1034
2018
Q2
$5.95M Buy
220,824
+231
+0.1% +$5.88K 0.01% 987
2018
Q1
$5.83M Buy
220,593
+2,662
+1% +$70.9K 0.01% 937
2017
Q4
$6.55M Buy
217,931
+1,413
+0.7% +$42.7K 0.01% 905
2017
Q3
$6.45M Buy
216,518
+1,058
+0.5% +$32.1K 0.01% 891
2017
Q2
$6.7M Buy
215,460
+40,717
+23% +$1.28M 0.02% 838
2017
Q1
$5.5M Buy
174,743
+14,968
+9% +$454K 0.01% 948
2016
Q4
$4.65M Buy
159,775
+19,494
+14% +$574K 0.01% 971
2016
Q3
$4.58M Buy
140,281
+9,371
+7% +$310K 0.01% 929
2016
Q2
$4.23M Buy
130,910
+37,397
+40% +$1.13M 0.01% 904
2016
Q1
$2.75M Buy
93,513
+5,680
+6% +$157K 0.01% 1167
2015
Q4
$2.37M Buy
87,833
+1,835
+2% +$47.3K 0.01% 1244
2015
Q3
$2.11M Sell
85,998
-9,052
-10% -$223K 0.01% 1288
2015
Q2
$2.28M Buy
95,050
+17,209
+22% +$440K 0.01% 1309
2015
Q1
$2.17M Buy
77,841
+2,130
+3% +$59.9K 0.01% 1351
2014
Q4
$2.04M Buy
75,711
+3,066
+4% +$77.6K 0.01% 1336
2014
Q3
$1.69M Sell
72,645
-596
-0.8% -$14.5K 0.01% 1441
2014
Q2
$1.76M Buy
73,241
+32,556
+80% +$775K 0.01% 1466
2014
Q1
$927K Buy
40,685
+1,565
+4% +$34.1K ﹤0.01% 1852
2013
Q4
$770K Buy
39,120
+1,130
+3% +$24K ﹤0.01% 1989
2013
Q3
$799K Buy
37,990
+30
+0.1% +$648 ﹤0.01% 1922
2013
Q2
$853K Buy
+37,960
New +$913K ﹤0.01% 1875

Other funds holding HR